Levetiracetam
Product Images NDC 53808-0376

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 53808-0376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Levetiractam Structural Formula (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 01)

Levetiractam Structural Formula (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 01)
FDA Label Image

Figure 1: Responder Rate (greater Than Or Equal To 50% Reduction From Baseline) In Study 1 (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 02)

Figure 1: Responder Rate (greater Than Or Equal To 50% Reduction From Baseline) In Study 1 (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 02)
This appears to be a table that is not properly formatted for , therefore it is not possible to provide a useful description.*
FDA Label Image

Figure 2: Responder Rate (greater Than Or Equal To 50% Reduction From Baseline) In Study 2: Period A (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 03)

Figure 2: Responder Rate (greater Than Or Equal To 50% Reduction From Baseline) In Study 2: Period A (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 03)
FDA Label Image

Figure 3: Responder Rate (greater Than Or Equal To 50% Reduction From Baseline) In Study 3 (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 04)

Figure 3: Responder Rate (greater Than Or Equal To 50% Reduction From Baseline) In Study 3 (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 04)
FDA Label Image

Figure 4: Responder Rate (greater Than Or Equal To 50% Reduction From Baseline) (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 05)

Figure 4: Responder Rate (greater Than Or Equal To 50% Reduction From Baseline) (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 05)
The text describes a statistical result of 44.6% and 19.6% that are significant versus placebo for an unknown variable. The value "Phcte 50 Lovsracen (100" is fragmented and not clear.*
FDA Label Image

Pediatric Patient Oral Solution Calculation (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 06)

Pediatric Patient Oral Solution Calculation (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 06)
This text provides a formula to calculate the total daily dose in milliliters for a patient based on their weight and the daily dose in milligrams per kilogram. The formula is: Daily dose (mg/kg/day) x patient weight (kg) = Total daily dose (mL/day). The concentration of the medication is 100 mg/mL.*
FDA Label Image

Creatinine Clearance Calculation (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 07)

Creatinine Clearance Calculation (3df96d02 Dd76 4b97 A189 Bc69c1e6c08d 07)
This is a formula to calculate the estimated creatinine clearance (CLer) using the patient's age, weight, and serum creatinine level. The formula is different for female patients, who have a coefficient of 0.85. However, this description is not complete without additional information on how the CLer result should be interpreted or used in a clinical setting.*
FDA Label Image

Levetiracetam Tablets 500 mg Bottles (Levetiracetam 500mg(mylan))

Levetiracetam Tablets 500 mg Bottles (Levetiracetam 500mg(mylan))

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.